Response to photodynamic therapy combined with intravitreal aflibercept for polypoidal choroidal vasculopathy depending on fellow-eye condition:2-year results
Open Access
- 11 August 2020
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (8) , e0237330
Abstract
We investigated whether response to photodynamic therapy (PDT) with intravitreal aflibercept injection (IAI) for polypoidal choroidal vasculopathy (PCV) differs depending on fellow eye condition. A retrospective review was conducted for consecutive 60 eyes with PCV treated with PDT combined with IAI as well as 2-years of follow-up data. Fellow eyes were divided into 4 groups; Group 0: no drusen, Group 1; pachydrusen, Group 2; soft drusen, Group 3: PCV/fibrovascular scarring. Best-corrected visual acuity improved at 24-months irrespective of groups and there were no significant differences in visual improvement among treated eyes among the 4 groups. Within 2-years, 35 (58.3%) required the retreatment. The need for retreatment including additional injection and the combination therapy was significantly less in Group 1(12.5%) compared to the others (P = 0.0038) and mean number of additional IAI was also less in Group 1 compared to the others (P = 0.017). The retreatment-free period from the initial combination therapy was longest in Group 1 (23.6±1.1 months) (P = 0.0055, Group 0: 19.1±6.9, Group 2: 12.8±7.9, Group 3: 11.5±9.9). The need for retreatment was significantly different according to fellow-eye condition. Among PCV patients, pachydrusen in fellow eyes appear to be a predictive characteristic for a decreased treatment burden at 2 years.Keywords
Funding Information
- Japan Society for the Promotion of Science Kakenhi Grant (23791972)
This publication has 39 references indexed in Scilit:
- Factors Associated with Recurrence of Age-Related Macular Degeneration after Anti-Vascular Endothelial Growth Factor TreatmentOphthalmology, 2015
- New loci and coding variants confer risk for age-related macular degeneration in East AsiansNature Communications, 2015
- Aqueous Humor Cytokine Levels in Patients with Polypoidal Choroidal Vasculopathy and Neovascular Age-Related Macular DegenerationOphthalmic Research, 2014
- Two-Year Results of Photodynamic Therapy With or Without Intravitreal Ranibizumab for Polypoidal Choroidal VasculopathyJournal of Ocular Pharmacology and Therapeutics, 2013
- SYSTEMIC RISK FACTORS ASSOCIATED WITH POLYPOIDAL CHOROIDAL VASCULOPATHY AND NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONRetina, 2013
- EVEREST STUDYRetina, 2012
- Clinical Characteristics of Exudative Age-related Macular Degeneration in Japanese PatientsAmerican Journal of Ophthalmology, 2007
- INDOCYANINE GREEN VIDEOANGIOGRAPHY OF IDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHYRetina, 1995
- Digital Indocyanine Green Videoangiography of Central Serous ChorioretinopathyArchives of Ophthalmology (1950), 1994
- IDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHY (IPCV)Retina, 1990